Progression from Hashimoto’s thyroiditis to Graves’ disease: Case 2
| Age | TSH μU/mL (0.3-4) |
Free T4 ng/dL (0.77-1.94) |
T3 ng/mL (0.75-1.9) |
TBII IU/L (0-1.5) |
Anti-TPO antibody U/mL (0-60) |
Anti-Tg antibody U/mL (0-60) |
LT dose (mg) | MM dose (mg) |
|---|---|---|---|---|---|---|---|---|
| 11 y, 6 m | 26.72 | 0.75 | 1.36 | Nd |
286.01 | 168.73 | 0.05 q.d. |
- |
| 11 y, 9 m | 0.07 | 2.35 | 2.40 | Nd | Nd | Nd | 0.025 q.d. | - |
| 11 y, 10 m | 0.001 | 3.49 | 3.75 | Nd | Nd | Nd | D/C |
- |
| 11 y, 11 m | 0.001 | 3.40 | 3.25 | 34.37 | 281.83 | Nd | D/C | 7.5 b.i.d. |
| 13 y, 8 m | 65.97 | 0.81 | 1.48 | 3.09 | Nd | Nd | D/C | D/C |
| 13 y, 9 m | 3.45 | 1.22 | 1.71 | Nd | 3334.7 | 114.11 | D/C | D/C |
*Nd: not done
†q.d.: q1d, every day
‡D/C: discontinue